Researchers Develop New Generation Tumor-specific Pro-IL-12
In a study published in Science Immunology, Prof. PENG Hua at the Institute of Biophysics of the Chinese Academy of Sciences and Prof. FU Yangxin at the University of Texas Southwestern Medical Center, and the collaborators, developed a new generation IL-12, the pro-IL-12, with low toxicity, tumor restriction, and high anti-tumor efficiency.
Jan 07, 2022